Protein kinase 2 (CK2): a potential regulator of immune cell development and function in cancer

Protein kinase 2 (CK2): a potential regulator of immune cell development and function in cancer

Protein kinase CK2, formally known as casein kinase II, is ubiquitously expressed and highly conserved serine/threonine or tyrosine kinase enzyme that regulates diverse signaling pathways responsible for cellular processes (i.e., cell proliferation and apoptosis) via interactions with over 500 known...

Full description

Bibliographic Details
Main Authors:	Kazim Husain, Tanika T. Williamson, Nadine Nelson, Tomar Ghansah
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-07-01
Series:	Immunological Medicine
Subjects:	protein kinase ck2 immune cells cancer chemotherapy ck2 inhibitors and immunotherapy
Online Access:	http://dx.doi.org/10.1080/25785826.2020.1843267

Similar Items

The Immune Regulatory Role of Protein Kinase CK2 and Its Implications for Treatment of Cancer
by: Huixian Hong, et al.
Published: (2021-12-01)

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders
by: Andrea Baier, et al.
Published: (2022-10-01)

CK2—An Emerging Target for Neurological and Psychiatric Disorders
by: Julia Castello, et al.
Published: (2017-01-01)

Copper Modulates the Catalytic Activity of Protein Kinase CK2
by: John E. Chojnowski, et al.
Published: (2022-06-01)

The protein kinase CK2 catalytic domain from Plasmodium falciparum : crystal structure, tyrosine kinase activity and inhibition
by: Ruiz-Carrillo, David, et al.
Published: (2018)

Protein Kinase CK2α’, More than a Backup of CK2α
by: Mathias Montenarh, et al.
Published: (2023-12-01)

Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
by: Zaira Spinello, et al.
Published: (2021-04-01)

Emerging role of Protein Kinase CK2 in Tumor immunity
by: Leichong Chen, et al.
Published: (2022-12-01)

Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection
by: Ailyn C. Ramón, et al.
Published: (2022-03-01)

Analysis of the phosphoproteome of CK2α(–/–)/Δα′ C2C12 myoblasts compared to the wild-type cells
by: Christian Borgo, et al.
Published: (2023-02-01)

Downfalls of Chemical Probes Acting at the Kinase ATP-Site: CK2 as a Case Study
by: Eleanor L. Atkinson, et al.
Published: (2021-03-01)

Formulation and Investigation of CK2 Inhibitor-Loaded Alginate Microbeads with Different Excipients
by: Boglárka Papp, et al.
Published: (2023-11-01)

CK2 and the Hallmarks of Cancer
by: May-Britt Firnau, et al.
Published: (2022-08-01)

Role of protein kinase CK2 in antitumor drug resistance
by: Christian Borgo, et al.
Published: (2019-07-01)

Synthesis of Novel Acyl Derivatives of 3-(4,5,6,7-Tetrabromo-1<i>H</i>-benzimidazol-1-yl)propan-1-ols—Intracellular TBBi-Based CK2 Inhibitors with Proapoptotic Properties
by: Konrad Chojnacki, et al.
Published: (2021-06-01)

Search of protein kinase CK2 inhibitors based on purine-2,6-diones derivatives
by: M. V. Protopopov, et al.
Published: (2017-10-01)

Asemptomatik kreatin kinaz (CK) yüksekliği: Hiper-CK-emi
by: Oğuz Abdullah Uyaroğlu
Published: (2020-06-01)

Role of Protein Kinase CK2 in Aberrant Lipid Metabolism in Cancer
by: Barbara Guerra, et al.
Published: (2020-10-01)

Targeting Casein Kinase 1 (CK1) in Hematological Cancers
by: Pavlína Janovská, et al.
Published: (2020-11-01)

SGC-CK2-1 Is an Efficient Inducer of Insulin Production and Secretion in Pancreatic β-Cells
by: Mandy Pack, et al.
Published: (2021-12-01)

Study of gastrointestinal neoplasms, histopathologic and immunohistochemical correlation using HER-2/NEU, CK-7 and CK-20
by: Pramod Kumar Reddy M, et al.
Published: (2023-07-01)

Casein Kinase 2 (CK2): A Possible Therapeutic Target in Acute Myeloid Leukemia
by: Øystein Bruserud, et al.
Published: (2023-07-01)

Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor
by: Karsten Niefind, et al.
Published: (2017-01-01)

Contribution of the CK2 Catalytic Isoforms α and α’ to the Glycolytic Phenotype of Tumor Cells
by: Francesca Zonta, et al.
Published: (2021-01-01)

Identification of a Potent Allosteric Inhibitor of Human Protein Kinase CK2 by Bacterial Surface Display Library Screening
by: Christian Nienberg, et al.
Published: (2017-01-01)

Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS Overproduction
by: Sofia Giacosa, et al.
Published: (2021-02-01)

Inhibition of CK2 Reduces NG2 Expression in Juvenile Angiofibroma
by: Anne S. Boewe, et al.
Published: (2022-04-01)

Novel small molecule protein kinase CK2 inhibitors exert potent antitumor effects on T98G and SEGA cells in vitro
by: Emanuela Pucko, et al.
Published: (2019-09-01)

Exploring the Activity of Fungal Phenalenone Derivatives as Potential CK2 Inhibitors Using Computational Methods
by: Sabrin R. M. Ibrahim, et al.
Published: (2022-04-01)

The Link between Protein Kinase CK2 and Atypical Kinase Rio1
by: Konrad Kubiński, et al.
Published: (2017-02-01)

Editorial: Casein kinases in human diseases
by: Andrea Venerando, et al.
Published: (2022-12-01)

Role of protein kinases CK1α and CK2 in multiple myeloma: regulation of pivotal survival and stress-managing pathways
by: Sabrina Manni, et al.
Published: (2017-10-01)

Recent Advances in the Discovery of CK2 Allosteric Inhibitors: From Traditional Screening to Structure-Based Design
by: Xiaolan Chen, et al.
Published: (2020-02-01)

Ablation of Protein Kinase CK2β in Skeletal Muscle Fibers Interferes with Their Oxidative Capacity
by: Nane Eiber, et al.
Published: (2017-01-01)

Evaluation of creatine kinase (CK)-MB to total CK ratio as a diagnostic biomarker for primary tumors and metastasis screening
by: Yan Li, et al.
Published: (2023-11-01)

Myeloid Cell CK2 Regulates Inflammation and Resistance to Bacterial Infection
by: Sandy R. Larson, et al.
Published: (2020-12-01)

Inhibiting CK2 among Promising Therapeutic Strategies for Gliomas and Several Other Neoplasms
by: Emanuela B. Pucko, et al.
Published: (2022-01-01)

An Iron Shield to Protect Epigallocatehin-3-Gallate from Degradation: Multifunctional Self-Assembled Iron Oxide Nanocarrier Enhances Protein Kinase CK2 Intracellular Targeting and Inhibition
by: Luca Fasolato, et al.
Published: (2021-08-01)

EFFECT OF INHIBITORS OF PROTEIN KINASE CK2 ON THE ACTIVITY ITS CATALYTIC SUBUNITS СК2α AND СК2α′
by: O. V. Ostrynska, et al.
Published: (2014-12-01)

Targeting protein kinases for anti-glioma treatment
by: Emanuela Pucko, et al.
Published: (2021-01-01)